abstract |
The invention relates to the use of an antibiotic of the 2-deoxystreptamine type, in particular a 2-deoxystreptamine 4,6 or 4,5 substituted by amino sugars, for the inhibition of the development of organisms containing introns. of group I, in particular in a process for the manufacture of a medicament. |